Precision BioSciences, Inc. (DTIL)
6.67
0.00 (0.00%)
USD |
NASDAQ |
Sep 18, 16:00
6.66
-0.01
(-0.15%)
Pre-Market: 20:00
Precision BioSciences Price to Book Value : 3.893 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.893 |
| September 17, 2026 | 3.893 |
| September 16, 2026 | 3.869 |
| September 15, 2026 | 3.858 |
| September 14, 2026 | 4.004 |
| September 11, 2026 | 4.184 |
| September 10, 2026 | 4.225 |
| September 09, 2026 | 4.231 |
| September 08, 2026 | 4.319 |
| September 04, 2026 | 4.360 |
| September 03, 2026 | 4.301 |
| September 02, 2026 | 4.348 |
| September 01, 2026 | 4.459 |
| August 31, 2026 | 4.459 |
| August 28, 2026 | 4.540 |
| August 27, 2026 | 4.902 |
| August 26, 2026 | 4.955 |
| August 25, 2026 | 4.990 |
| August 24, 2026 | 4.932 |
| August 21, 2026 | 5.165 |
| August 20, 2026 | 5.089 |
| August 19, 2026 | 4.961 |
| August 18, 2026 | 4.803 |
| August 17, 2026 | 4.319 |
| August 14, 2026 | 4.336 |
| Date | Value |
|---|---|
| August 13, 2026 | 4.260 |
| August 12, 2026 | 4.330 |
| August 11, 2026 | 4.383 |
| August 10, 2026 | 4.354 |
| August 07, 2026 | 4.371 |
| August 06, 2026 | 4.330 |
| August 05, 2026 | 4.360 |
| August 04, 2026 | 4.249 |
| August 03, 2026 | 4.120 |
| July 31, 2026 | 4.079 |
| July 30, 2026 | 4.085 |
| July 29, 2026 | 4.021 |
| July 28, 2026 | 4.184 |
| July 27, 2026 | 4.231 |
| July 24, 2026 | 4.254 |
| July 23, 2026 | 4.278 |
| July 22, 2026 | 4.272 |
| July 21, 2026 | 4.447 |
| July 20, 2026 | 4.295 |
| July 17, 2026 | 4.593 |
| July 16, 2026 | 4.856 |
| July 15, 2026 | 5.142 |
| July 14, 2026 | 5.007 |
| July 13, 2026 | 5.013 |
| July 10, 2026 | 5.112 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen, Inc. | 17.84 |
| 4D Molecular Therapeutics, Inc. | 2.061 |
| Agenus, Inc. | -- |
| Anika Therapeutics, Inc. | 2.029 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 3.016 |
| Price | 6.67 |
| Earnings Yield | -42.72% |
| Market Cap | 176.31M |